Axogen, Inc. (AXGN) stock
AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30145% above fair value
$56.35−0.60 (-1.05%)
Close on Nov 19, 2026Market cap $3.37BP/E –Yield –
Axogen shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Axogen's shares outstanding was 62M at Sep 30, 2026. For fiscal 2025 it was 46M, up 4.1% from the year before. Over ten years it grew 5.9% a year on average. The highest annual figure on record is 46M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46M | +4.1% |
| FY2024 | Dec 31, 2024 | 44M | +3.2% |
| FY2023 | Dec 31, 2023 | 43M | +1.9% |
| FY2022 | Dec 31, 2022 | 42M | +2.1% |
| FY2021 | Dec 31, 2021 | 41M | +3.1% |
| FY2020 | Dec 31, 2020 | 40M | +1.9% |
| FY2019 | Dec 31, 2019 | 39M | +5.7% |
| FY2018 | Dec 31, 2018 | 37M | +111315.5% |
| FY2017 | Dec 31, 2017 | 0M | +8.5% |
| FY2016 | Dec 31, 2016 | 0M | -99.9% |
| FY2015 | Dec 31, 2015 | 26M | +47.1% |
| FY2014 | Dec 31, 2014 | 18M | +31.3% |
| FY2013 | Dec 31, 2013 | 13M | +21.7% |
| FY2012 | Dec 31, 2012 | 11M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 62M | +25.3% |
| Q2 FY2026 | Jun 30, 2026 | 53M | +11.2% |
| Q1 FY2026 | Mar 31, 2026 | 52M | +14.1% |
| Q4 FY2025 | Dec 31, 2025 | 46M | +0.6% |
| Q3 FY2025 | Sep 30, 2025 | 49M | +11.9% |
| Q2 FY2025 | Jun 30, 2025 | 48M | +9.8% |
| Q1 FY2025 | Mar 31, 2025 | 45M | +4.6% |
| Q4 FY2024 | Dec 31, 2024 | 46M | +7.3% |
| Q3 FY2024 | Sep 30, 2024 | 44M | +2.0% |
| Q2 FY2024 | Jun 30, 2024 | 44M | +2.0% |
| Q1 FY2024 | Mar 31, 2024 | 43M | +1.6% |
| Q4 FY2023 | Dec 31, 2023 | 43M | +1.8% |
| Q3 FY2023 | Sep 30, 2023 | 43M | +1.9% |
| Q2 FY2023 | Jun 30, 2023 | 43M | +2.1% |
| Q1 FY2023 | Mar 31, 2023 | 43M | +1.8% |
| Q4 FY2022 | Dec 31, 2022 | 42M | +1.7% |
| Q3 FY2022 | Sep 30, 2022 | 42M | +1.8% |
| Q2 FY2022 | Jun 30, 2022 | 42M | +2.2% |
| Q1 FY2022 | Mar 31, 2022 | 42M | +2.7% |
| Q4 FY2021 | Dec 31, 2021 | 42M | +3.4% |
| Q3 FY2021 | Sep 30, 2021 | 41M | +3.4% |
| Q2 FY2021 | Jun 30, 2021 | 41M | +3.2% |
| Q1 FY2021 | Mar 31, 2021 | 41M | +2.5% |
| Q4 FY2020 | Dec 31, 2020 | 40M | +1.9% |
| Q3 FY2020 | Sep 30, 2020 | 40M | +1.9% |
| Q2 FY2020 | Jun 30, 2020 | 40M | +1.7% |
| Q1 FY2020 | Mar 31, 2020 | 40M | +2.0% |
| Q4 FY2019 | Dec 31, 2019 | 39M | +1.9% |
| Q3 FY2019 | Sep 30, 2019 | 39M | +2.2% |
| Q2 FY2019 | Jun 30, 2019 | 39M | +6.8% |
| Q1 FY2019 | Mar 31, 2019 | 39M | +12.8% |
| Q4 FY2018 | Dec 31, 2018 | 39M | +16.4% |
| Q3 FY2018 | Sep 30, 2018 | 39M | +16.2% |
| Q2 FY2018 | Jun 30, 2018 | 37M | +11.1% |
| Q1 FY2018 | Mar 31, 2018 | 35M | – |
| Q3 FY2017 | Sep 30, 2017 | 33M | – |
| Q2 FY2017 | Jun 30, 2017 | 33M | – |
| Q1 FY2017 | Mar 31, 2017 | 33M | – |
See a number that looks wrong?